drugset / Trial / NCT07313072
Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.
Timeline
- Start
- 2026-09-01
- Primary completion
- 2027-04
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tofacitinib | Small molecule | 2 % | Topical |